The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ASNA, RMED and PYX

NEW YORK, NY / ACCESSWIRE / June 17, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Ascena Retail Group, Inc. (ASNA)

Investors Affected : September 16, 2015 - June 8, 2017

A class action has commenced on behalf of certain shareholders in Ascena Retail Group, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) the ANN Acquisition was a complete disaster for the Company as Ann's operations were in far worse condition than had been represented to the public; (b) in order to mask the true condition of Ann, Defendants improperly delayed recognizing an impairment charge to the value of Ann's goodwill and, as a result, Ascena's reported income and assets were materially overstated and the Company's financial results were not prepared in conformity with GAAP; (c) many of the brands acquired in the ANN Acquisition were in steep decline and were also materially overvalued on Ascena's Class Period financial statements; and (d) as a result of the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company, its operations and prospects.

Shareholders may find more information at https://securitiesclasslaw.com/securities/ascena-retail-group-inc-loss-submission-form/?id=1971&from=1

RA Medical Systems, Inc. (RMED)

Investors Affected : stockholders that purchased Ra Medical securities pursuant and/or traceable to the Company's September 2018 initial public offering.

A class action has commenced on behalf of certain shareholders in RA Medical Systems, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's evaluation of sales personnel candidates was inadequate; (2) the Company's training program for sales personnel was inadequate; (3) as a result, the Company could not reasonably assure that its newly hired sales personnel were adequately experienced; (4) as a result, the Company would suffer a shortage of qualified sales personnel; (5) the Company's manufacturing process could not reasonably support increased catheter production; (6) as a result, the Company would suffer production delays; and (7) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/ra-medical-systems-inc-loss-submission-form/?id=1971&from=1

Pyxus International, Inc. (PYX)

Investors Affected : on behalf of stockholders who purchased Pyxus (f/k/a Alliance One International, Inc. (AOI)) securities between June 7, 2018 and November 8, 2018, inclusive.

A class action has commenced on behalf of certain shareholders in Pyxus International, Inc . The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing longer shipping cycles; (2) as a result, the Company's financial results would be materially affected; (3) the Company lacked adequate internal control over financial reporting; (4) the Company's accounting policies were reasonably likely to lead to regulatory scrutiny; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/pyxus-international-inc-f-k-a-alliance-one-international-inc-loss-submission-form/?id=1971&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

View source version on accesswire.com:
https://www.accesswire.com/548988/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-ASNA-RMED-and-PYX